| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D N Osse. A systematic approach to the classification and pharmacotherapy of nonpsychotic major depression and dysthymia. Journal of clinical psychopharmacology. vol 13. issue 2. 1993-05-06. PMID:8463446. |
after family and past history of response and cost of drug are considered, a tricyclic antidepressant is usually selected for autonomous depression patients, and mood-reactive depression patients are initially given a serotonin reuptake inhibitor. |
1993-05-06 |
2023-08-12 |
Not clear |
| D G Schlundt, K L Virts, T Sbrocco, J Pope-Cordle, J O Hil. A sequential behavioral analysis of craving sweets in obese women. Addictive behaviors. vol 18. issue 1. 1993-05-03. PMID:8465679. |
these data are not consistent with the hypothesis that sweet craver's consume high-carbohydrate, low-protein meals and snacks in order to self-medicate depression caused by serotonin depletion. |
1993-05-03 |
2023-08-12 |
human |
| Y God. [Ventilatory mechanical analysis of respiratory depression induced by serotonin]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science. vol 68. issue 1. 1993-04-02. PMID:8444402. |
[ventilatory mechanical analysis of respiratory depression induced by serotonin]. |
1993-04-02 |
2023-08-12 |
rat |
| D J Kupfe. Management of recurrent depression. The Journal of clinical psychiatry. vol 54 Suppl. 1993-04-02. PMID:8444832. |
the results of 1-year studies of maintenance therapy with serotonin selective reuptake inhibiting agents suggest that these medications will play a major role in prophylaxis for recurrent depression. |
1993-04-02 |
2023-08-12 |
Not clear |
| J P Ottervanger, P M van den Bemt, G H de Koning, B H Stricke. [Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)]. Nederlands tijdschrift voor geneeskunde. vol 137. issue 5. 1993-03-12. PMID:8433763. |
fluoxetine (prozac) and fluvoxamine (fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. |
1993-03-12 |
2023-08-12 |
Not clear |
| H M van Praa. About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 2. issue 4. 1993-03-01. PMID:1362659. |
5-ht disturbances in depression (as exemplified by lowered csf 5-hiaa) are not syndrome specific but related to components of the depressive syndrome, specifically to increased anxiety and aggression. |
1993-03-01 |
2023-08-11 |
Not clear |
| H M van Praa. About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 2. issue 4. 1993-03-01. PMID:1362659. |
in "5-ht related depression", the key psychopathological disturbances are dysregulation of anxiety and aggression, while mood lowering is a "by-product". |
1993-03-01 |
2023-08-11 |
Not clear |
| H M van Praa. About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 2. issue 4. 1993-03-01. PMID:1362659. |
based on this hypothesis it was predicted that agents which ameliorate anxiety and/or aggression via harmonization of 5-ht ergic transmission will, in addition, exert overall antidepressant effect in "5-ht related depression". |
1993-03-01 |
2023-08-11 |
Not clear |
| S Dey, R H Singh, P K De. Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise. Physiology & behavior. vol 52. issue 6. 1993-02-17. PMID:1283013. |
these findings have been discussed in an attempt to explain the antidepressant effect of exercise based on the 5ht deficiency theory of endogenous depression. |
1993-02-17 |
2023-08-11 |
rat |
| S J Warringto. Clinical implications of the pharmacology of serotonin reuptake inhibitors. International clinical psychopharmacology. vol 7 Suppl 2. 1993-02-17. PMID:1484174. |
the similarities between the ssris are more obvious than their differences: all are highly potent and selective inhibitors of serotonin reuptake with efficacy in the treatment of depression. |
1993-02-17 |
2023-08-11 |
Not clear |
| J Mendel. The acute and long-term treatment of major depression. International clinical psychopharmacology. vol 7 Suppl 2. 1993-02-17. PMID:1484175. |
the availability of a new class of antidepressant medications--the selective serotonin reuptake inhibitors (ssris)--heralds a new phase in the treatment of depression. |
1993-02-17 |
2023-08-11 |
Not clear |
| C Thompso. Bridging the gap between psychiatric practice and primary care. International clinical psychopharmacology. vol 7 Suppl 2. 1993-02-17. PMID:1484176. |
however, prescriptions of the selective serotonin reuptake inhibitors (ssris) for depression are gradually increasing here and in other countries such as the usa, france and canada, where the ssris as a class account for upwards of 30% of new antidepressant prescriptions. |
1993-02-17 |
2023-08-11 |
Not clear |
| G Chouinar. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies. International clinical psychopharmacology. vol 7 Suppl 2. 1993-02-17. PMID:1484177. |
sertraline is a non-tricyclic, potent and selective serotonin reuptake inhibitor (ssri) which is currently approved for the treatment of depression in several countries, including the uk and the usa. |
1993-02-17 |
2023-08-11 |
Not clear |
| K P Lesch, C S Aulakh, B L Wolozin, D L Murph. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. Pharmacology & toxicology. vol 71 Suppl 1. 1993-02-11. PMID:1480560. |
serotonin (5-ht) receptor, 5-ht transporter and g protein-effector expression: implications for depression. |
1993-02-11 |
2023-08-11 |
Not clear |
| S E Mølle. Serotonin, carbohydrates, and atypical depression. Pharmacology & toxicology. vol 71 Suppl 1. 1993-02-11. PMID:1480561. |
serotonin, carbohydrates, and atypical depression. |
1993-02-11 |
2023-08-11 |
rat |
| P Celada, J Pérez, E Alvarez, F Artiga. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. Journal of clinical psychopharmacology. vol 12. issue 5. 1993-02-10. PMID:1282522. |
monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. |
1993-02-10 |
2023-08-11 |
Not clear |
| P Celada, J Pérez, E Alvarez, F Artiga. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. Journal of clinical psychopharmacology. vol 12. issue 5. 1993-02-10. PMID:1282522. |
plasma 5-ht increased more markedly in responders than in nonresponders and a significant inverse relationship surfaced between plasma 5-ht and the hamilton rating scale for depression. |
1993-02-10 |
2023-08-11 |
Not clear |
| B Mårtensso. [Selective serotonin uptake in depression. Same therapeutic effect as tricyclic agents but better side effect profile and lower toxicity?]. Lakartidningen. vol 89. issue 50. 1993-01-27. PMID:1469979. |
[selective serotonin uptake in depression. |
1993-01-27 |
2023-08-11 |
Not clear |
| R Krulík, Z Fisa. [Adrenergic and serotonergic receptors during depression and its therapy]. Ceskoslovenska psychiatrie. vol 88. issue 5. 1993-01-06. PMID:1451201. |
the hypothesis are based on changes of levels of serotonin and noradrenaline and on changes of their binding sites during depression and its treatment. |
1993-01-06 |
2023-08-11 |
Not clear |
| Selective Serotonin Uptake Inhibitors in Depression and Other Indications. Symposium proceedings. Florence, Italy, 11 June 1991. International clinical psychopharmacology. vol 6 Suppl 5. 1992-12-23. PMID:1358940. |
selective serotonin uptake inhibitors in depression and other indications. |
1992-12-23 |
2023-08-11 |
Not clear |